PER 34.1% 8.9¢ percheron therapeutics limited

$15m cap raise Fresh Equities at 24c, page-783

  1. 98 Posts.
    lightbulb Created with Sketch. 16
    The drop thus far isnt just due to the partnership rumour IMO. (Look at where SP was 26c @ Jan this year). A genuine Sarepta deal would inflate our SP far above 35c

    Management decision to give existing shareholders (including instos) a second bite of the cherry with a future dated entitlement. Possibility of third top up for instos if retail opts out just incentivises instos to sell to keep the price below fair value of options + 0.24 rights issue

    All just amplified the usual games of CR time and i think a poor decision at best in hindsight..

    Hopefully things pick up quickly once the dust settles
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.